Medical Diagnostic Laboratories (MDL) provides comprehensive pathology testing, from Epstein-Barr virus (EBV), h.pylori, and Candida, to various Lyme disease co-infections.
Founded int 1997, Medical Diagnostic Laboratories, L.L.C. (MDL) serves mainly as a reference laboratory for molecular diagnostic based testing to laboratories, hospitals and physicians worldwide. The success of MDL is attributed directly to client retention through our ability to customize our unique services to specifically address the individual needs of our clients. Enhanced turn-around time, cost effectiveness, and the capability to tailor services to best suit the needs and budgets of our clients gives MDL a distinct advantage over its competitors. MDL offers unique, non-invasive, highly stable specimen collection and transport platforms, such as the OneSwab®, UroSwab® and NasoSwab®. These platforms enable MDL to offer a variety of PCR based tests from a single swab with high sensitivity and specificity.
MDL specializes in high complexity, state-of-the-art, automated DNA-based molecular analysis. By utilizing molecular techniques, MDL is able to provide clinicians from many different specialties valuable diagnostic information to assist in the detection, diagnosis, evaluation, and treatment of bacterial, viral and fungal infections as well as genetic based testing and cancer diagnostics. For example, the unique testing MDL offers for the specialties of Urology, Gynecology and Pediatric Medicine enables the detection of multiple pathogens as well as certain drug resistance profiles from a single swab by Polymerase Chain Reaction (PCR) testing. MDL’s primary focus is in the fields of infectious disease testing for Women’s Health and Gynecology, Pediatric Respiratory Infections, Urology, Vector-borne Diseases, Mycology and chronic illnesses.
MDL is comprised of experts in the fields of Molecular Biology, Immunology, Virology, Microbiology, Mycology, Pharmacogenomics, Antimicrobial Resistance and Oncology. In addition to developing and validating new clinical diagnostic tests, the Research and Development Department also publishes research projects in peer-reviewed journals, presents scientific information at international symposia, and performs contractual research work for major commercial, governmental, and academic organizations.